Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Amcr Institute Inc.
Escondido, California, United States
Recruiting - Rocky Mountain Diabetes Center, Llc. (rmdc)
Idaho Falls, Idaho, United States
David LiljenquistRecruiting - Clinical Trials of Texas, Llc. (ctt)
San Antonio, Texas, United States
Douglas S Denham, DORecruiting - Rainier Clinical Research Center
Renton, Washington, United States
Ronald Brazg, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Oct 2021
- Primary completion
- 30 Mar 2025
- Completion
- 30 Sept 2025
- Last update posted
- 26 Apr 2023
- Registered enrollment
- 350
- Registry id
- NCT05131139
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.